IRIS
DI MUZIO, NADIA GISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.784
AS - Asia 5.182
NA - Nord America 5.111
SA - Sud America 1.400
Continente sconosciuto - Info sul continente non disponibili 339
AF - Africa 144
OC - Oceania 14
AN - Antartide 1
Totale 17.975
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.799
RU - Federazione Russa 2.882
SG - Singapore 1.911
CN - Cina 1.551
BR - Brasile 1.143
IT - Italia 1.068
HK - Hong Kong 655
SE - Svezia 609
VN - Vietnam 515
RO - Romania 272
FR - Francia 257
DE - Germania 175
BD - Bangladesh 145
CA - Canada 137
GB - Regno Unito 102
AR - Argentina 93
FI - Finlandia 85
ES - Italia 80
IN - India 80
MX - Messico 66
ZA - Sudafrica 51
NL - Olanda 50
ID - Indonesia 45
EC - Ecuador 44
IE - Irlanda 40
AT - Austria 38
CO - Colombia 38
IQ - Iraq 35
TR - Turchia 35
UA - Ucraina 32
JM - Giamaica 28
JP - Giappone 26
PL - Polonia 26
PY - Paraguay 25
CR - Costa Rica 22
UZ - Uzbekistan 21
SA - Arabia Saudita 19
MA - Marocco 17
MY - Malesia 17
PE - Perù 16
PK - Pakistan 16
EG - Egitto 14
KE - Kenya 14
PH - Filippine 14
TT - Trinidad e Tobago 14
VE - Venezuela 14
CL - Cile 13
TN - Tunisia 13
NP - Nepal 11
AU - Australia 10
JO - Giordania 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
IR - Iran 9
SV - El Salvador 9
TH - Thailandia 9
DZ - Algeria 8
UY - Uruguay 8
EU - Europa 7
HN - Honduras 7
LT - Lituania 7
MD - Moldavia 7
PR - Porto Rico 7
PT - Portogallo 7
TW - Taiwan 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
MK - Macedonia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
BO - Bolivia 4
CG - Congo 4
CH - Svizzera 4
DK - Danimarca 4
GT - Guatemala 4
KR - Corea 4
LB - Libano 4
NZ - Nuova Zelanda 4
ZW - Zimbabwe 4
CZ - Repubblica Ceca 3
GR - Grecia 3
IL - Israele 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SC - Seychelles 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GP - Guadalupe 2
KG - Kirghizistan 2
LV - Lettonia 2
Totale 17.615
Salva come PNG Salva come JPEG
Città #
Singapore 866
Ashburn 807
Moscow 655
Hong Kong 640
Dallas 576
San Jose 543
Council Bluffs 332
Milan 323
Shanghai 323
Hefei 244
Beijing 238
Lauterbourg 223
Princeton 205
Lawrence 204
Ho Chi Minh City 181
New York 156
Hanoi 129
Santa Clara 108
Los Angeles 95
São Paulo 91
Rome 74
Phoenix 68
Helsinki 58
Munich 51
Miano 45
Naples 44
Valencia 44
Nuremberg 41
Brooklyn 37
Orem 35
Chicago 34
Dublin 33
Boardman 32
Rio de Janeiro 32
Omaha 28
Belo Horizonte 27
Montreal 27
Atlanta 25
Da Nang 25
Denver 25
Johannesburg 25
Brasília 23
Chennai 23
Washington 23
Bologna 22
Guangzhou 22
Toronto 22
Mexico City 21
San José 21
Tokyo 21
Guayaquil 19
Boston 18
Curitiba 18
Houston 18
Manchester 18
Warsaw 18
Frankfurt am Main 17
Haiphong 17
Seattle 17
Tashkent 17
Amsterdam 16
London 16
Biên Hòa 15
Can Tho 15
Genoa 15
Kingston 15
Poplar 15
Stockholm 15
Buffalo 14
Figino 14
Shenzhen 14
Charlotte 13
Porto Alegre 13
Thái Bình 13
Vienna 13
Brescia 12
Dhaka 12
Lappeenranta 12
Mumbai 12
Pune 12
Quito 12
St Louis 12
Baghdad 11
Bogotá 11
Cape Town 11
Fortaleza 11
Goiânia 11
Ipatinga 11
Tampa 11
Ankara 10
Campinas 10
Irvine 10
Las Vegas 10
Manaus 10
North Bergen 10
Osasco 10
Philadelphia 10
Salvador 10
The Dalles 10
Turin 10
Totale 8.611
Salva come PNG Salva come JPEG
Nome #
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer 343
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 246
Health-related quality of life 24 months after prostate cancer diagnosis: An update from the Pros-IT CNR prospective observational study 215
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 193
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 185
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 176
A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in rats 174
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 157
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 153
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer 152
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 149
A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer 148
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 146
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 145
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 137
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 134
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 133
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells 130
Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index 128
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 127
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 127
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study 126
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 125
A Case of Radiotherapy During Pregnancy for Oropharyngeal Cancer: Long-Term Pediatric Outcome Evaluation and Literature Review 124
Patients with Cardiac Implantable Electronic Device Undergoing Radiation Therapy: Insights from a Ten-Year Tertiary Center Experience 120
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 120
Predictors of patient-reported incontinence at adjuvant/salvage radiotherapy after prostatectomy: Impact of time between surgery and radiotherapy 118
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 116
Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review 113
A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer 112
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers 111
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 111
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 106
Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy 105
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 104
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial 102
Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016 97
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 97
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 96
Repeat gamma knife radiosurgery for recurrent pituitary adenomas. 95
Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review 92
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 89
Ocular leukemic mass-like relapse treated with CyberKnife stereotactic radiosurgery 89
Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy 88
La qualità della vita del paziente col tumore alla prostata sottoposto a trattamento radioterapico: uno studio prospettico 86
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration 86
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study 85
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study 85
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 84
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation 84
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 82
Quality indicators in the intensity modulated/image-guided radiotherapy era 82
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT 81
Pros-IT CNR: an Italian prostate cancer monitoring project 81
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: A single-institute analysis of 742 patients 80
Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges 80
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 79
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study 79
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 79
Knowledge-based automatic optimization of adaptive early-regression-guided VMAT for rectal cancer 79
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience 78
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. 78
Knowledge-based automatic plan optimization for left-sided whole breast tomotherapy 76
Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas 76
Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial 75
Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer? 74
Modelling the impact of fractionation on late urinary toxicity after postprostatectomy radiation therapy 74
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy 73
More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis 73
Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 73
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 73
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized? 73
Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy 72
Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters 72
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 72
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 72
Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases 72
Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation 71
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 70
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 70
Re: Marcin Miszczyk, Pawel Rajawa, Takafumi Yanagisawa, et al. The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. Eur Urol. 2024;85:125–38 69
Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: The impact of competing causes of mortality and patient stratification 69
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 69
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 69
Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC 69
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy 69
Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison 69
Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients 69
Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design 69
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients 68
Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy 68
NEED FOR HIGH RADIATION DOSE (>= 70 GY) IN EARLY POSTOPERATIVE IRRADIATION AFTER RADICAL PROSTATECTOMY: A SINGLE-INSTITUTION ANALYSIS OF 334 HIGH-RISK, NODE-NEGATIVE PATIENTS 68
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak 68
Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison 68
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 68
Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma. 67
Significant reduction of acute toxicity following pelvic irradiation with Helical Tomotherapy in patients with localized prostate cancer 67
Defining the Right State for a Will Rogers Phenomenon in Oligometastatic Prostate Cancer 67
La qualità di vita del paziente con tumore alla prostata sottoposto a trattamento radioterapico 66
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases 66
Totale 10.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022143 0 0 0 88 4 7 10 8 12 6 1 7
2022/20231.108 472 233 75 6 0 117 42 77 46 5 11 24
2023/2024675 11 35 59 127 46 113 22 54 18 42 53 95
2024/20253.319 431 72 53 117 105 247 680 200 548 370 212 284
2025/20269.940 707 822 939 1.391 732 236 850 636 2.507 548 313 259
2026/20272.595 473 626 530 966 0 0 0 0 0 0 0 0
Totale 17.975